Arax Advisory Partners’s Accendra Health ACH Stock Holding History

Arax Advisory Partners’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$164K	Buy	47,890 +47,821	+69,306%	+$149K	﹤0.01%	2388
2026 Q1	$46	Sell	69 -28,517	-100%	-$65.7K	﹤0.01%	3665
2025 Q4	$80K	Sell	28,586 -28,126	-50%	-$101K	﹤0.01%	1416
2025 Q3	$272K	Buy	56,712 +56,417	+19,124%	+$359K	﹤0.01%	1124
2025 Q2	$2.69K	Sell	295 -13	-4%	-$96	﹤0.01%	2460
2025 Q1	$2.78K	Buy	+308	New	+$3.25K	﹤0.01%	1976
2024 Q4	–	Sell	-12	Closed	-$189	–	2653
2024 Q3	$189	Hold	12	–	–	﹤0.01%	2518
2024 Q2	$162	Buy	+12	New	+$246	﹤0.01%	2458

Other funds holding ACH

CCM

Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Arax Advisory Partners's ACH Position: Q2 2026 in Review

Arax Advisory Partners increased its Accendra Health (ACH) stake by 69,306% in Q2 2026, buying an estimated $149K and bringing the position to 47,890 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #2388.

Arax Advisory Partners first reported a position in ACH in Q2 2024 and has held it in 8 quarters since. The position peaked at $272K in Q3 2025. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

Arax Advisory Partners held 47,890 shares of Accendra Health worth $164K as of Q2 2026.
Arax Advisory Partners bought 47,821 Accendra Health shares in Q2 2026, an estimated $149K.
Accendra Health made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2388 holding.
Arax Advisory Partners first reported a position in Accendra Health in Q2 2024 and has held it in 8 quarters since.
Arax Advisory Partners's Accendra Health position peaked at $272K in Q3 2025.
139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.